Investment Company Myconic Capital Agrees To Buy Mindscape Ketamine & Infusions Therapy benzinga.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from benzinga.com Daily Mail and Mail on Sunday newspapers.
Operator
Greetings, and welcome to the Paratek Pharmaceuticals fourth-quarter and full-year 2020 earnings conference call. [Operator instructions] As a reminder, this conference is being recorded. I d now like to turn the conference over to your host, Ben Strain, vice president of investor relations. Please go ahead, sir.
Ben Strain
Vice President of Investor Relations
Good afternoon, and welcome to Paratek s fourth-quarter and full-year 2020 earnings and corporate update conference call. A press release for the company s fourth-quarter and full-year results was issued earlier today, and we ve also posted slides on our website that will be referred to on this call. Both can be found at www.paratekpharma.com. Participants on today s call are Evan Loh, CEO; Adam Woodrow, president and chief commercial officer; Randy Brenner, chief development and regulatory officer; Michael Bigham, executive chairman; and Sarah Higgins, vice president of finance, controller, and principal accoun
Examining the Ugandan health system’s readiness to deliver rheumatic heart disease-related services
Emma Ndagire, Roles Formal analysis, Writing – original draft, Writing – review & editing
Affiliations Uganda Heart Institute, Kampala, Uganda, Children’s National Hospital, Division of Cardiology, Washington, District of Columbia, United States of America ⨯
Yoshito Kawakatsu,
Affiliation Department of Global Health, University of Washington, Seattle, Washington, United States of America
Affiliation Uganda Heart Institute, Kampala, Uganda
Affiliation Uganda Heart Institute, Kampala, Uganda Roles Formal analysis, Writing – review & editing
Affiliation Children’s National Hospital, Division of Cardiology, Washington, District of Columbia, United States of America ⨯
Jafesi Pulle,
Affiliation Uganda Heart Institute, Kampala, Uganda
The Citizen brings you breaking news, current affairs, celebrity and entertainment news, as well as sport news throughout the day. More news. Your way.
As controversy swirls around the use of a well-known anti-parasitic drug Ivermectin, commonly used in animals and to treat scabies and head lice in humans, against the Covid-19 coronavirus, the SA Health Products Authority (Sahpra) which had previously taken a hard line against the drug, now says it would welcome and expedite applications for its clinical trials.
Further, the local regulatory authority has said it’s also open to considering enabling access to improved formulations of the drug for human use through a Section 21 authorisation of the Medicines and Related Substances Act – which allows Sahpra to authorise the sale of an unregistered medicine for a certain purpose for a specified period.